Home > Insider Trading > Filing (0001209191-20-057368)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204660	P Charles Slacik	9975 Summers Ridge Road San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-05	4,009	$20.82	15,224	No	4	M	Direct
Common Stock	Disposition	2020-11-05	4,009	$282.46	11,215	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option	Disposition	2020-11-05	4,009	$0.00	4,009	$20.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2016-05-05	2025-11-16	No	4	M	Direct

Footnotes

The amount of securities beneficially owned following this transaction include a reduction of shares due to the prior gifting of 137 shares by the reporting person to a bona fide charitable organization.
The weighted average sale price for these transactions was $282.4614 per share, with a range of $282.11 to $282.60. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.